PYTX 00n
Alternative Names: PYTX-00nLatest Information Update: 31 Oct 2022
At a glance
- Originator Imperial College of Science, Technology and Medicine; Papyrus Therapeutics
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 10 Oct 2022 Early research in Solid tumours in United Kingdom, prior to October 2022 (Papyrus Therapeutics pipeline, October 2022)
- 10 Oct 2022 Early research in Solid tumours in USA, prior to October 2022 (Papyrus Therapeutics pipeline, October 2022)
- 10 Oct 2022 Papyrus Therapeutics plans development candidate selection in Q4 2022 (Papyrus Therapeutics pipeline, October 2022).